Skip to main content

and
  1. Article

    Open Access

    A Phospholipid Profile at 4 Months Predicts the Onset of Celiac Disease in at-Risk Infants

    Celiac disease (CeD) is a multifactorial disease influenced by both genetic and environmental risk factors. CeD genetic components are mainly due to HLA class II genes, which account for approximately 40% of t...

    R. Auricchio, M. Galatola, D. Cielo, A. Amoresano, M. Caterino in Scientific Reports (2019)

  2. Article

    Open Access

    A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study

    Docetaxel (75 mg m−2 3-weekly) is standard second-line treatment in advanced non-small-cell lung cancer (NSCLC) with significant toxicity. To verify whether a weekly schedule (33.3 mg m−2 for 6 weeks) improved qu...

    C Gridelli, C Gallo, M Di Maio, E Barletta, A Illiano in British Journal of Cancer (2004)

  3. Article

    Open Access

    Supportive care in patients with advanced non-small-cell lung cancer

    The present study describes supportive care (SC) in patients with advanced non-small-cell lung cancer (NSCLC), evaluating whether it is affected by concomitant chemotherapy, patient's performance status (PS) a...

    M Di Maio, F Perrone, C Gallo, R V Iaffaioli, L Manzione in British Journal of Cancer (2003)